ETV1-BTBD9 Fusion FISH Probe
The ETV1-BTBD9 Fusion FISH Probe is used to confirm a fusion of the ETV1 and BTBD9 genes. The fusion of the ETV1 and BTBD9 genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ETV1-BTBD9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ETV1-BTBD9-20-AQAQ | 20 (40 μL) | 200 μL |
|
ETV1 Gene Summary
This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5'-CGGA[AT]-3'. The protein encoded by this gene contains a conserved short acidic transactivation domain (TAD) in the N-terminal region, in addition to the ETS DNA-binding domain in the C-terminal region. This gene is involved in chromosomal translocations, which result in multiple fusion proteins including EWS-ETV1 in Ewing sarcoma and at least 10 ETV1 partners (see PMID: 19657377, Table 1) in prostate cancer. In addition to chromosomal rearrangement, this gene is overexpressed in prostate cancer, melanoma and gastrointestinal stromal tumor. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2016]
Gene Name: ETS Variant 1
Chromosome: CHR7: 13930855 -14031050
Locus: 7p21.2
BTBD9 Gene Summary
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
Gene Name: BTB Domain Containing 9
Chromosome: CHR6: 38136226 -38607924
Locus: 6p21.2
Gene Diseases
The ETV1 BTBD9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Sarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|